Team:BIT/nb
Journal
March:
i. Week 1-2(2017.03.04-2017.03.17)
After discussion, the main goal of our project was to detect cancer of the liver by using small molecule
ii. Week 3(2017.03.18-2017.03.24)
After reviewing the literature, we chose lysine as our small molecule and chose lysine-deficient E.coli as our bacteria.
iii. week 4(2017.03.25-2017.03.31)
We chose our main experimental method.
April:
i. Week 5(2017.04.01-2017.04.07)
We listed the plasmids we might use, designed the gene lines, began to construct our part.
ii. Week 6(2017.04.08-2017.04.14)
We constructed our first part BBa_K2305008.
iii. Week 7(2017.04.15-2017.04.21)
We constructed our part BBa_K2305011、BBa_K2305012 and BBa_K2305003、BBa_K2305002.
iv. Week 8(2017.04.22-2017.04.28)
We import BBa_K876070 to E.coli, detect the growth and fluorescence curve of E.coil under various lysine concentration.
May:
i. Strength:
1. Convenience.
2. Adaptability.
3. High Cost/Performance Ratio.
4. Inelastic to change in test conditions.
ii. Weakness:
1. Technology Barrier.
2. Branding Barrier.
3. Strict Market Admittance Criteria.
4. Distribution Barrier.
iii. Opportunity:
1. Favorable national economic condition.
2. Positive national policies.
3. Uprising Health-consciousness.
iv. Threats:
1. Well-established industries control the high-end markets with related products.
2. Industrial chain is currently complete
3. Technological applications are matured
June:
Hire Us!
Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.
